Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 3
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11400067 | AQNEURSAlevacetylleucine | use | Apr 2037 |
| 12433862 | AQNEURSAlevacetylleucine | use | Apr 2037 |
| 12433863 | AQNEURSAlevacetylleucine | use | Apr 2037 |
| Product | Exclusivity | Until |
|---|---|---|
| AQNEURSALEVACETYLLEUCINE | ODE-498 Orphan drug | Sept 2031 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AQNEURSA | levacetylleucine | granule, for suspension, oral | 83853-101NDA |
Compare
Other companies listing levacetylleucine
- Patheon Manufacturing Services LLC19 sites · 319 NDC
Enquiry
Common questions
- Is IntraBio Inc FDA approved?
- IntraBio Inc holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does IntraBio Inc make?
- 1 product is listed under IntraBio Inc in the openFDA NDC Directory, most often as granule, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.